bluebird bio Reports Third Quarter 2023 Financial Results and Highlights Operational ProgressBusiness Wire • 11/07/23
bluebird bio to Present New and Updated Data from Gene Therapy Programs in Sickle Cell Disease and Beta-Thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting and ExpositionBusiness Wire • 11/02/23
Bluebird Bio (BLUE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZacks Investment Research • 10/31/23
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain PatientThe Motley Fool • 10/30/23
Bluebird bio to sell sickle cell gene therapy FDA voucher for $103 million if approvedReuters • 10/30/23
bluebird bio Enters into Advance Agreement to Sell Priority Review Voucher, if Granted, for $103 MillionBusiness Wire • 10/30/23
Cathie Wood Is Buying This Growth Stock Hand Over Fist Lately. Should You Follow Her Lead?The Motley Fool • 10/03/23
2 Growth Stocks That Could Rocket 88% to 99% Higher According to Wall StreetThe Motley Fool • 09/12/23
Bluebird (BLUE) Up 7.3% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 09/07/23
August MDA Breakout Stocks Week 35 - 2023: High-Frequency Gainers To Give You An EdgeSeeking Alpha • 08/28/23
1 Beaten-Down Growth Stock You'd Regret Not Buying on the Dip, According to Wall StreetThe Motley Fool • 08/24/23